Arş. Gör. ZEHRA ÖZSOY

1. Recommendations of the Turkish Society for Rheumatology on tuberculosis screening and treatment in patients receiving advanced antirheumatic drug therapy Gelişmiş antiromatizmal ilaç tedavisi alacak hastalarda tüberküloz taraması ve tedavisi için Türkiye Romatoloji Derneği önerileri

Bes C., Deniz R., EKİCİ M., İlgen U., İnce B., Özsoy Z., et al.

Journal of Turkish Society For Rheumatology , cilt.18, sa.2, ss.140-149, 2026 (Scopus, TRDizin)

2. Efficacy, retention, and safety of baricitinib in real-life: HUR-BIO monocentric experience Baricitinibin gerçek hayattaki etkinliği, kalıcılığı ve güvenliği: HÜR-BİO tek merkezli deneyimi

EKİCİ M., İçli İ. Y., Deregözü E. E., BİLGİN E., ÖZSOY Z., AYAN G., et al.

Journal of Turkish Society For Rheumatology , cilt.18, sa.1, ss.108-118, 2026 (Scopus, TRDizin)

3. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience

Ediboglu E. D., KALYONCU U., SOLMAZ D., YAŞAR BİLGE N. Ş., Yilmaz S., Bes C., et al.

ARCHIVES OF RHEUMATOLOGY , cilt.40, sa.1, ss.1-14, 2025 (SCI-Expanded, Scopus, TRDizin)

4. Computed tomography imaging-based radiologic evaluation of pulmonary artery thrombosis in a series of patients with Behcet's disease

GERME Ş. A., ÖZSOY Z., Bulat B., DURHAN G., FIRLATAN B., KILIÇ L., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.27, sa.7, 2024 (SCI-Expanded, Scopus)

5. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

BİLGİN E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.

Internal and Emergency Medicine , cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded, Scopus)

6. Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication

ÖZSOY Z., AYAN G., DURHAN G., KALYONCU U.

Rheumatology (United Kingdom) , cilt.63, sa.4, ss.1147-1152, 2024 (SCI-Expanded, Scopus)

7. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

Sandal Uzun G., Taghiyeva A., Çakır İ. Y., Moral K., YARDIMCI G. K., Bölek E. Ç., et al.

International Journal of Rheumatic Diseases , cilt.27, sa.1, 2024 (SCI-Expanded, Scopus)

8. Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?

ÖZSOY Z., ÖZDEMİR A., EKİCİ M., BİLGİN E., KILIÇ L., KİRAZ S., et al.

Rheumatology International , cilt.43, sa.8, ss.1445-1451, 2023 (SCI-Expanded, Scopus)

9. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

Duran E., Ozturk Z. O., BİLGİN E., BÜYÜKAŞIK Y., DİZDAR Ö., Yardimci G. K., et al.

Rheumatology and Therapy , cilt.10, sa.4, ss.969-981, 2023 (SCI-Expanded, Scopus)

10. Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone

Kiracı M., BİLGİN E., Duran E., Farisoğulları B., Bölek E., Yardımcı G., et al.

Scandinavian Journal of Rheumatology , cilt.52, sa.5, ss.530-538, 2023 (SCI-Expanded, Scopus)

11. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results

AYAN G., Farisogullari B., BİLGİN E., BÖLEK E. Ç., KubraYardimci G., DURAN E., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1439-1446, 2022 (SCI-Expanded, Scopus)

12. Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis

Bostan E., GÜLSEREN D., ÖZSOY Z., Ergen F. B.

Archives of Rheumatology , cilt.37, sa.1, ss.148-149, 2022 (SCI-Expanded, Scopus, TRDizin)

13. Comparison of Demographic, Clinic and Radiological Features of Axial Spondyloarthritis Patients with and Without Accompanying Familial Mediterranean Fever

Kiraci M., BİLGİN E., Duran E., Farisogullari B., Bolek E. C., YARDIMCI G. K., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.73, ss.771-773, 2021 (SCI-Expanded, Scopus)

Arş. Gör. ZEHRA ÖZSOY

Yayınlar & Eserler

1. Recommendations of the Turkish Society for Rheumatology on tuberculosis screening and treatment in patients receiving advanced antirheumatic drug therapy Gelişmiş antiromatizmal ilaç tedavisi alacak hastalarda tüberküloz taraması ve tedavisi için Türkiye Romatoloji Derneği önerileri

2. Efficacy, retention, and safety of baricitinib in real-life: HUR-BIO monocentric experience Baricitinibin gerçek hayattaki etkinliği, kalıcılığı ve güvenliği: HÜR-BİO tek merkezli deneyimi

3. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience

4. Computed tomography imaging-based radiologic evaluation of pulmonary artery thrombosis in a series of patients with Behcet's disease

5. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

6. Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication

7. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

8. Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?

9. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

10. Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone

11. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results

12. Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis

13. Comparison of Demographic, Clinic and Radiological Features of Axial Spondyloarthritis Patients with and Without Accompanying Familial Mediterranean Fever

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim